Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicine
Fabio Blandini, Roberto Cilia, Silvia Cerri, et al.
Movement Disorders (2018) Vol. 34, Iss. 1, pp. 9-21
Closed Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

GBA, Gaucher Disease, and Parkinson’s Disease: From Genetic to Clinic to New Therapeutic Approaches
Giulietta Riboldi, Alessio Di Fonzo
Cells (2019) Vol. 8, Iss. 4, pp. 364-364
Open Access | Times Cited: 244
The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson’s Disease
Kai-Jung Lin, Kai-Lieh Lin, Shang‐Der Chen, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 21, pp. 5312-5312
Open Access | Times Cited: 104
Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?
Yvette C. Wong, Kelvin C. Luk, Kerry Purtell, et al.
Movement Disorders (2019) Vol. 34, Iss. 10, pp. 1406-1422
Open Access | Times Cited: 90
The Role of Cholesterol in α‐Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease
Patricia García‐Sanz, Johannes M. F. G. Aerts, Rosario Moratalla
Movement Disorders (2020) Vol. 36, Iss. 5, pp. 1070-1085
Open Access | Times Cited: 89
The gut microbiome in Parkinson's disease: A culprit or a bystander?
Ali Keshavarzian, Phillip A. Engen, Salvatore Bonvegna, et al.
Progress in brain research (2020), pp. 357-450
Closed Access | Times Cited: 85
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease
Micol Avenali, Fabio Blandini, Silvia Cerri
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 75
Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson’s disease and their targeted therapeutic approaches: a comprehensive review
Tapan Behl, Gagandeep Kaur, Ovidiu Frăţilă, et al.
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 66
Targeting the GBA1 pathway to slow Parkinson disease: Insights into clinical aspects, pathogenic mechanisms and new therapeutic avenues
Elisa Menozzi, Marco Toffoli, Anthony H.V. Schapira
Pharmacology & Therapeutics (2023) Vol. 246, pp. 108419-108419
Open Access | Times Cited: 24
More than meets the eye in Parkinson’s disease and other synucleinopathies: from proteinopathy to lipidopathy
Manuel Flores‐León, Tiago F. Outeiro
Acta Neuropathologica (2023) Vol. 146, Iss. 3, pp. 369-385
Open Access | Times Cited: 24
GBA Variants in Parkinson's Disease: Clinical, Metabolomic, and Multimodal Neuroimaging Phenotypes
Andrea Greuel, Jean‐Pierre Trezzi, Enrico Glaab, et al.
Movement Disorders (2020) Vol. 35, Iss. 12, pp. 2201-2210
Open Access | Times Cited: 68
Mechanisms of alpha-synuclein toxicity: An update and outlook
Inês Caldeira Brás, Mary Xylaki, Tiago F. Outeiro
Progress in brain research (2019), pp. 91-129
Closed Access | Times Cited: 66
The Promise and Challenges of Developing miRNA-Based Therapeutics for Parkinson’s Disease
Simoneide Souza Titze-de-Almeida, Cristina Soto-Sánchez, Eduardo Fernández, et al.
Cells (2020) Vol. 9, Iss. 4, pp. 841-841
Open Access | Times Cited: 64
Genetic perspective on the synergistic connection between vesicular transport, lysosomal and mitochondrial pathways associated with Parkinson’s disease pathogenesis
Stefanie Smolders, Christine Van Broeckhoven
Acta Neuropathologica Communications (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 61
Mutated ATP10B increases Parkinson’s disease risk by compromising lysosomal glucosylceramide export
Shaun Martin, Stefanie Smolders, Chris Van den Haute, et al.
Acta Neuropathologica (2020) Vol. 139, Iss. 6, pp. 1001-1024
Open Access | Times Cited: 57
Exploring the Genotype–Phenotype Correlation in GBA-Parkinson Disease: Clinical Aspects, Biomarkers, and Potential Modifiers
Elisa Menozzi, Anthony H.V. Schapira
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 50
Parkinson’s Disease-Related Genes and Lipid Alteration
Milena Fais, Antonio Dore, Manuela Galioto, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7630-7630
Open Access | Times Cited: 42
A review on Gaucher disease: therapeutic potential of β-glucocerebrosidase-targeted mRNA/saRNA approach
Shunping Feng, Nino Rcheulishvili, Xiaoming Jiang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 6, pp. 2111-2129
Open Access | Times Cited: 6
GBA1-associated parkinsonism: new insights and therapeutic opportunities
Emory Ryan, Gurpreet Seehra, Pankaj Sharma, et al.
Current Opinion in Neurology (2019) Vol. 32, Iss. 4, pp. 589-596
Closed Access | Times Cited: 52
Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update—I. Hypokinetic-rigid movement disorders
K. A. Jellinger
Journal of Neural Transmission (2019) Vol. 126, Iss. 8, pp. 933-995
Closed Access | Times Cited: 43
Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson’s disease
Giulietta Riboldi, Ricardo A. Vialle, Elisa Navarro, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 25
'Fly-ing' from rare to common neurodegenerative disease mechanisms
Mengqi Ma, Matthew J. Moulton, Shenzhao Lu, et al.
Trends in Genetics (2022) Vol. 38, Iss. 9, pp. 972-984
Open Access | Times Cited: 23
Recalibrating the Why and Whom of Animal Models in Parkinson Disease: A Clinician’s Perspective
Andrea Sturchio, Emily M. Rocha, Marcelo Kauffman, et al.
Brain Sciences (2024) Vol. 14, Iss. 2, pp. 151-151
Open Access | Times Cited: 5
Reduced progranulin increases tau and α-synuclein inclusions and alters mouse tauopathy phenotypes via glucocerebrosidase
Hideyuki Takahashi, Sanaea Bhagwagar, Sarah Helena Nies, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
The Current State-of-the Art of LRRK2-Based Biomarker Assay Development in Parkinson’s Disease
Hardy J. Rideout, Marie‐Christine Chartier‐Harlin, Matthew Fell, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 39
Profiling the Biochemical Signature of GBA‐Related Parkinson's Disease in Peripheral Blood Mononuclear Cells
Micol Avenali, Silvia Cerri, Gerardo Ongari, et al.
Movement Disorders (2021) Vol. 36, Iss. 5, pp. 1267-1272
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top